Last reviewed · How we verify

NCT06891690: tDCS

Use of TDCS Stimulation in Neurological and Gynaecological Conditions

Recruiting now NA Last updated 24 March 2025
What this trial tests

NA trial testing tDSC stimulation in Stroke in 300 participants. Currently enrolling.

Timeline
5 February 2025
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorPoznan University of Physical Education
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment300
Start date5 February 2025
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Poznan University of Physical Education

Who can join

Adults 18 to 90, any sex, with Stroke or Spinal Cord Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a single tDCS with mirror therapy stimulation on hand function in healthy individuals.
    Wójcik M, Vlček P, Siatkowski I, Grünerová-Lippertová M. · · 2025 · cited 2× · PMID 40606492 · DOI 10.3389/fnhum.2025.1607022

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Poznan University of Physical Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06891690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing